Fundz

Geneos Therapeutics, Inc. reported raising $10.4 Million in an initial SEC Form D filing, from an offering of $12 Million

PRIVATENov 17, 2020$10.4M of $12M raised

Amount Raised

$10.4 Million

$10.4 Million sold, per SEC Form D (first sale Nov 17, 2020)

Round Type

Venture

Plymouth MeetingBiotechnologyHealth CareScience And Engineering

Quick answer

Geneos Therapeutics raised $10.4 Million in a funding round, dated November 17, 2020. Geneos Therapeutics is based in Plymouth Meeting, Pennsylvania, United States.

How much did Geneos Therapeutics raise?
Geneos Therapeutics raised $10.4 Million in a funding round on November 17, 2020.
What does Geneos Therapeutics do?
Geneos Therapeutics, a privately held, clinical stage biotherapeutics company, believes that the company's personalized therapeutic cancer vaccines (PTCVs) may serve an important role in new immunotherapeutic paradigms..
Where is Geneos Therapeutics based and how big is it?
Geneos Therapeutics is based in Plymouth Meeting, Pennsylvania, United States.
Who are the decision-makers at Geneos Therapeutics?
Fundz holds 2 contacts at Geneos Therapeutics, including the Vice President Head Of Operations Business Development. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Biotechnology around the same time

Companies in the same sectors as Geneos Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Viracta Therapeutics raised $40M on December 10, 2020.
  • Memo Therapeutics AG raised an undisclosed amount (Series B) on November 6, 2020.
  • Unlearn raised an undisclosed amount (Series A) on November 5, 2020.
  • Bond Biosciences raised $3.1M on November 4, 2020.
  • Dewpoint Therapeutics raised $77M on November 2, 2020.
  • Appili Therapeutics Inc. raised $6M (Funding Round) on October 27, 2020.

Who to call at Geneos Therapeutics, and when

A new round usually means Geneos Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Geneos Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Geneos Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Geneos Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Geneos Therapeutics

Location

Plymouth Meeting, Pennsylvania, United States

About

Geneos Therapeutics, a privately held, clinical stage biotherapeutics company, believes that the company's personalized therapeutic cancer vaccines (PTCVs) may serve an important role in new immunotherapeutic paradigms for cancer. The company's approach, using its proprietary GT-EPIC™ platform, is to target neoantigens (abnormal mutations produced by cancer cells) from individual patient tumors to develop novel and uniquely personalized treatments for cancer. Planning is underway for a potentially registrational clinical trial in advanced hepatocellular carcinoma. Geneos' experienced management team has a track record of success in building immunotherapy-based companies. For more information, please visit www.geneostx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Geneos Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJoann P., Vice President Head Of Operations Busin…See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Geneos Therapeutics's next move

See what Strategic adds

Geneos Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.